{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:29:42Z","timestamp":1781562582614,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejogrb.2020.07.015","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T04:10:28Z","timestamp":1594786228000},"page":"404-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Meta-analysis of the diagnostic accuracy of HE4 for endometrial carcinoma"],"prefix":"10.1016","volume":"252","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiLi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayinuer","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejogrb.2020.07.015_bib0005","first-page":"212","article-title":"Cancer statistics, 2011","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"9484","key":"10.1016\/j.ejogrb.2020.07.015_bib0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.07.015_bib0015","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2008.19.4.218","article-title":"Gynecologic oncology group trials in uterine corpus malignancies: recent progress","volume":"19","author":"Miller","year":"2008","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.07.015_bib0020","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0025","first-page":"341","article-title":"Epidemiology of endometrial cancer","volume":"15","author":"Puedie","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaeool"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.07.015_bib0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/uog.1704","article-title":"How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding","volume":"24","author":"Smith-Bindman","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.07.015_bib0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/erm.09.39","article-title":"HE4 as a biomarker for ovarian and endometrial cancer management","volume":"9","author":"Li","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"issue":"9213","key":"10.1016\/j.ejogrb.2020.07.015_bib0040","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versussurgery alone for patients with stage\u2014I endometrial carcinoma:multicentre randomized trial.PORTEC Study Group. Post operative radiation therapy inendometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus","volume":"110","author":"M oore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0050","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","article-title":"Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts","volume":"100","author":"Huhtinen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jcla.20340","article-title":"The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass","volume":"23","author":"Montagnana","year":"2009","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.07.015_bib0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00404-006-0138-y","article-title":"etc.Pelviclymph adenectomy as altemative to postoperative radiotherapy in high risk early stage endometrial cancer","volume":"274","author":"Papanikolaou","year":"2006","journal-title":"Arch Gynecol Obestet"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.07.015_bib0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/erm.09.39","article-title":"HE4 as a biomarker for ovarian and endometrial cancer management","volume":"9","author":"Li","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0070","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s13277-013-1190-4","article-title":"A critical review on HE4 performance in endometrial cancer: where are we now?","volume":"35","author":"Angioli","year":"2014","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.07.015_bib0075","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehansive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Path01."},{"issue":"4","key":"10.1016\/j.ejogrb.2020.07.015_bib0080","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.12669\/pjms.334.12755","article-title":"Value of HE4 combined with Cancer antigen 125 in the diagnosis of endometrial cancer","volume":"33","author":"Dong","year":"2017","journal-title":"Pak J Med Sci"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.07.015_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22223","article-title":"The clinical significance of DJ-1 and HE4 in patients with endometrial cancer","volume":"32","author":"Benati","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0090","first-page":"820","volume":"22","author":"Zhao","year":"2012"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0095","series-title":"The value of human epididymal protein 4 in the diagnosis of endometrial carcinoma","first-page":"1","author":"Weizeng","year":"2014"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0100","first-page":"3496","article-title":"Combined detection of CA125, HE4 and ang \u2161 in the diagnosis of endometrial cancer","volume":"23","author":"Lv","year":"2015","journal-title":"Adv Mod Oncol Res"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.07.015_bib0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1533034616666644","article-title":"Clinical significance of serum HE4, CA125, CA724, and CA19-9 in patients with endometrial cancer","volume":"16","author":"Bian","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cca.2016.06.010","article-title":"Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China","volume":"459","author":"Li","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.ejogrb.2020.07.015_bib0115","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1515\/cclm-2011-0757","article-title":"Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome","volume":"50","author":"Zanotti","year":"2012","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"10.1016\/j.ejogrb.2020.07.015_bib0120","first-page":"XC01","article-title":"Diagnostic performance of serum human epididymis protein 4 in endometrial carcinoma: a pilot study","volume":"11","author":"Dewan","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0125","first-page":"47","article-title":"The clinical value of preoperative single and combined CA125 detection of HE4 in endometrial cancer","volume":"01","author":"Lin","year":"2014","journal-title":"Modern immunology"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0130","first-page":"1600","article-title":"Clinical value of combined detection of serum human epididymal protein 4, CA125 and CA19-9 in the diagnosis of endometrial cancer","volume":"11","author":"Pan","year":"2014","journal-title":"Chinese Journal of health inspection"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0135","first-page":"1068","article-title":"Clinical significance of detection of serum human epididymal protein 4 in the diagnosis of endometrial cancer","volume":"09","author":"Fang","year":"2015","journal-title":"Anhui Medical Journal"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0140","first-page":"1108","article-title":"The value of serum human epididymal protein E4, CA125, CA199 in the diagnosis of endometrial cancer","volume":"07","author":"Zhang","year":"2016","journal-title":"Journal of practical medicine"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0145","first-page":"73","article-title":"Changes and significance of serum HE4 and CA125 levels in patients with endometrial cancer","volume":"03","author":"Dong","year":"2017","journal-title":"Shandong medicine"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0150","first-page":"329","article-title":"Ruifeng Ren.Diagnostic value of HE4 in endometrial cancer","volume":"03","author":"Wang","year":"2015","journal-title":"Journal of practical cancer"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0155","first-page":"131","article-title":"The significance of HE4 and CA125 in the diagnosis of endometrial diseases","volume":"02","author":"Yi","year":"2018","journal-title":"Mod Health Care"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0160","unstructured":"Rong Ma, Xiaoxing Geng, Liping Tang, Shuang Liu. Significance of detection of human epididymal secretory protein 4 in diagnosis and prognosis of endometrial cancer. Journal of Clinical Oncology."},{"issue":"60","key":"10.1016\/j.ejogrb.2020.07.015_bib0165","first-page":"277","article-title":"Cancer statistics, 2010","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bpobgyn.2005.10.015","article-title":"Screening and the prevention of gyne-cologic cancer: endometrial cancer","volume":"20","author":"Sonoda","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"17","key":"10.1016\/j.ejogrb.2020.07.015_bib0175","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","article-title":"The putative ovarian Tumour mi - lker gene HFA(WFDC2) is expressed in normal tissues and UU der goes complex alternative splicing to yield multiple protein isoforms","volume":"21","author":"Bingle","year":"2002","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.07.015_bib0180","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4(HE4) is a secreted glycoprotein that is over expressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.07.015_bib0185","first-page":"265","article-title":"Prognostic significanceofHE4expressioninpulmonaryadenocarcinoma","volume":"32","author":"Yamashita","year":"2011","journal-title":"TumorBiology"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.07.015_bib0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbrc.2005.05.125","article-title":"Theevolutionofageneticlocusencodingsmallserineproteinaseinhibitors","volume":"333","author":"Clauss","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.ejogrb.2020.07.015_bib0195","doi-asserted-by":"crossref","first-page":"22655","DOI":"10.3390\/ijms141122655","article-title":"HE4 transcriptionand splice variants-specific expression in endometrial cancer and correlation with patient survival","volume":"14","author":"Jiang","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.ejogrb.2020.07.015_bib0200","first-page":"4779","article-title":"HE4expressioncanbeassociatedwithlymphnodemetastasesanddisease-free survivalinbreastcancer","volume":"30","author":"Kamei","year":"2010","journal-title":"AnticancerResearch"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.07.015_bib0205","first-page":"734","article-title":"Humanepididymisprotein4isupregulatedingastricandpancreaticadenocarcinomas","volume":"44","author":"O\u2019Neal","year":"2013","journal-title":"HumanPathology"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.07.015_bib0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jcla.20329","article-title":"Humanepi didymisprote in 4isabiomarker fortransitional cellcarcinomain the urinary system","volume":"23","author":"Xi","year":"2009","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.ejogrb.2020.07.015_bib0215","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant humam tissues","author":"Galgano","year":"2006","journal-title":"Med Path"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.07.015_bib0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jcla.20340","article-title":"The utilitY Of SclMmhu\u2014inan epididymi s protein4(HE4)in patient Swith a Pelvi c ITIII","volume":"23","author":"Montsgnana","year":"2009","journal-title":"JCiin Lab Anal"},{"issue":"7305","key":"10.1016\/j.ejogrb.2020.07.015_bib0225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests","volume":"323","author":"Deeks","year":"2001","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.07.015_bib0230","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.juro.2008.04.026","article-title":"How to use an article about a diagnostic test","volume":"180","author":"Scales","year":"2008","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.ejogrb.2020.07.015_bib0235","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.1994.03510330081039","article-title":"Users\u2019 guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group","volume":"271","author":"Jaeschke","year":"1994","journal-title":"JAMA"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520304577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520304577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:52:03Z","timestamp":1759557123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520304577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":47,"alternative-id":["S0301211520304577"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.07.015","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of the diagnostic accuracy of HE4 for endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}